Research Categories
- Anesthesia
- Arthroscopy
- Biologics/Biomaterials
- Cancer Devices
- Cardiovascular
- Cosmetic Devices
- Dental
- Diabetes
- Diagnostics
- Dialysis
- Drug Delivery
- Ear, Nose, Throat
- Endoscopy
- Gastrointestinal (GI)
- General Surgery
- Gynecology Devices
- Healthcare IT
- Hearing Devices
- Imaging
- Immunology
- Infusion Therapy
- Laparoscopy
- Minimally Invasive Surgery
- Neurology Devices
- Oncology
- Operating Room Equipment
- Ophthalmics Devices
- Orthopedics
- Patient Monitoring
- Peripheral Vascular
- Respiratory Devices
- Robotics & Navigation
- Sleep Apnea & Diagnostics
- Spine
- Stents
- Telehealth & Telemedicine
- Tissue Repair
- Urology
- Vascular Access
- Video Hi-Tech
- Women's Health
- Wound Care
Cardiac Rhythm Management
The Cardiac Rhythm Management market reports include research coverage on the following device segments: implantable cardioverter-defibrillators (ICDs), pacemakers, cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads and wearable defibrillators.
iData’s market research will provide insights into the following questions:
- How is COVID-19 the global Cardiac Rhythm Management Market?
- What is the Cardiac Rhythm Management market size in the U.S.?
- What factors are impacting the Cardiac Rhythm Management Market in the U.K.?
- What is the number of total procedures in the Cardiac Rhythm Management market in Japan? What procedure volumes are on the rise or decline within the segments in Japan?
- What are the major developments in the Cardiac Rhythm Management market in Germany? What impact did these have on the market share in Germany?
- Which competitors hold more market share within the cardiac surgery instruments market in South Korea?
Find your answers in the reports for: Asia Pacific, European, U.S. or Global
Showing all 11 results
Cardiac Rhythm Management Market Analysis, Size, Trends | Europe | 2019-2025 | MedSuite | Includes: Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy Devices, and 5 more

The total market for Europe’s cardiac rhythm management devices market is growing at a rate of 3.9%, which will take the 2018 market value of €2.2 billion up to €2.9 billion by 2025. Reprocessed diagnostic electrophysiology (EP) catheters accounted for a significant percentage of all diagnostic EP catheters used. Reprocessed catheters have a much lower […]
more...Cardiac Rhythm Management Market Size, Share, & COVID-19 Impact Analysis | Global | 2022-2028 | MedSuite | Includes: Pacemakers, Cardiac Ablation Catheters, and 6 more

The full report suite on the global market for cardiac rhythm management, electrophysiology & cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, implantable loop recorders (ILRs), electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.
more...Cardiac Rhythm Management Market Analysis, Size, Trends | United States | 2019-2025 | MedSuite | Includes: Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy Devices, and 5 more

In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the […]
more...